NCT06615349Recruiting
DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care
Summary
The aim of this study is to test if a system consisting of a wearable device measuring heartbeats and steps, together with daily communication with a chatbot on the smartphone asking the patients about their symptoms and giving tips, can reduce unplanned hospital readmissions and improve well-being in advanced cancer and severely ill patients.
Inclusion criteria
• Patients with established diagnosis of a metastatic cancer/severe illness with limited life expectancy receiving palliative care services • Estimated life expectancy \<24 months (physician's guess)/ \>3 months • Karnofsky Index ≥ 50% / ECOG≤ 2 • Aged \>18 years • Owns and uses a smartphone • Give written informed consent
Exclusion criteria
• Patients under curative treatment • Relevant cognitive impairment
Contacts
The trial team's contact details are shown on request.
See the official trial record- Status
- Recruiting
- Phase
- No phase (N/A)
- Study type
- Interventional
- Countries
- Switzerland
- Sponsor
- David Blum(Other)
- Protocol no.
- digiPall
- Conditions
- Terminal Illness, Terminal Cancer
- Interventions
- Behavioral
Treatments studied
- DigiPall
Collaborators
Zurich University of Applied Sciences
Locations · 1
- Zurich, SwitzerlandUniversity Hospital ZurichRecruiting at this site
In total, worldwide, the only site listed in the registry is recruiting.
Site status per the ClinicalTrials.gov registry (last update posted: July 10, 2025).
This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.
See also
Other versions
These results are indicative and do not replace medical advice — discuss them with your doctor.